{
  "id": 976,
  "text": "Two recurrences $( 3 3 \\% )$ were seen in patients with initial FIGO stage IB2 disease (with residual disease measuring $3 \\mathrm { m m }$ and $1 5 \\mathrm { m m } ^ { \\cdot }$ ), three $( 5 0 \\% )$ in patients with initial FIGO stage IB1 tumours of $2 \\mathrm { c m }$ or larger, and one $( 1 7 \\% )$ in a patient with an initial FIGO stage IB1 tumour smaller than $2 \\mathrm { c m }$ .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Two recurrences $( 3 3 \\% )$ were seen in patients with initial FIGO stage IB2 disease (with residual disease measuring $3 \\mathrm { m m }$ and $1 5 \\mathrm { m m } ^ { \\cdot }$ ), three $( 5 0 \\% )$ in patients with initial FIGO stage IB1 tumours of $2 \\mathrm { c m }$ or larger, and one $( 1 7 \\% )$ in a patient with an initial FIGO stage IB1 tumour smaller than $2 \\mathrm { c m }$ .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究数据，肿瘤大小在初始FIGO阶段为IB1和IB2的患者中对复发概率具有显著影响。对于FIGO IB1阶段的患者，如果肿瘤大小达到或超过2厘米，其复发概率显著升高（约为50%）；而直径小于2厘米的肿瘤，复发几率相对较低（约为17%）。对于FIGO阶段IB2的患者，尽管肿瘤更大，但复发的几率反而较低（约为33%），可能与其它因素如治疗方式和病理特征相关。因此，肿瘤大小是影响复发风险的重要因素之一，需结合患者的具体病情综合评估。",
  "query": "对于初始FIGO阶段为IB1及IB2的患者，肿瘤大小如何影响复发概率？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于初始FIGO阶段为IB1及IB2的患者，肿瘤大小如何影响复发概率？\n\n<reference text>: Two recurrences $( 3 3 \\% )$ were seen in patients with initial FIGO stage IB2 disease (with residual disease measuring $3 \\mathrm { m m }$ and $1 5 \\mathrm { m m } ^ { \\cdot }$ ), three $( 5 0 \\% )$ in patients with initial FIGO stage IB1 tumours of $2 \\mathrm { c m }$ or larger, and one $( 1 7 \\% )$ in a patient with an initial FIGO stage IB1 tumour smaller than $2 \\mathrm { c m }$ .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究数据，肿瘤大小在初始FIGO阶段为IB1和IB2的患者中对复发概率具有显著影响。对于FIGO IB1阶段的患者，如果肿瘤大小达到或超过2厘米，其复发概率显著升高（约为50%）；而直径小于2厘米的肿瘤，复发几率相对较低（约为17%）。对于FIGO阶段IB2的患者，尽管肿瘤更大，但复发的几率反而较低（约为33%），可能与其它因素如治疗方式和病理特征相关。因此，肿瘤大小是影响复发风险的重要因素之一，需结合患者的具体病情综合评估。"
}